TNF and COVID-19: From a molecular perspective, inhibition and inactivation of ASM provide anti-inflammatory properties by a decrease of tumor necrosis factor (TNF) α and interleukin (IL)-6 as well as - in a reflective manner - of IL-10 (31, 32), which are all highly correlated with morbidity and mortality rate of COVID-19 (33, 34).